Brief: Advaxis Announces Receipt Of Second Milestone Payment Under Adxs-Her2 Licensing Agreement With OS Therapies
26/04/2021 13:47
April 26 (Reuters) - Advaxis Inc ADXS.O :
* ADVAXIS ANNOUNCES RECEIPT OF SECOND MILESTONE PAYMENT
UNDER
ADXS-HER2 LICENSING AGREEMENT WITH OS THERAPIES
Source text for Eikon: ID:nGNX7nZgqF
Further company coverage: ADXS.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Ayala Pharmaceuticals
See all newsBrief: Ayala Pharmaceuticals Completes Sale Of AL102 To Immunome
Immunome slides on $200 mln equity offering
Immunome edges up after $200 mln equity offering
Brief: Immunome To Acquire AL102 Phase 3 Asset for the Treatment of Desmoid Tumors From Ayala Pharmaceuticals
Brief: Ayala Pharmaceuticals Announces AL102 Receives Orphan Drug Designation for Desmoid Tumors